Cite
APA Citation
Zahn, N. M., Huber, A. T., Mikulsky, B. N., Stepanski, M. E., Kehoe, A. S., Li, G., Schussman, M., Rashid Roni, M. S., Kodali, R., Cook, J. M., Stafford, D. C., Steeber, D. A., & Arnold, L. A. (2019). mIDD0301 – A first‐in‐class anti‐inflammatory asthma drug targets GABAA receptors without causing systemic immune suppression. Basic & clinical pharmacology & toxicology, 125(1), 75–84. http://access.bl.uk/ark:/81055/vdc_100086210776.0x00000f